Accessibility links

Breaking News

Bring Back Extinct Species? Ambitious Plan Draws Investors, Critics


Dr. Beth Shapiro, molecular biologist on Colossal Biosciences' scientific advisory board, and Ben Lamm, co-founder and CEO of Colossal Biosciences. (Image courtesy of Colossal Biosciences)
Dr. Beth Shapiro, molecular biologist on Colossal Biosciences' scientific advisory board, and Ben Lamm, co-founder and CEO of Colossal Biosciences. (Image courtesy of Colossal Biosciences)

The dodo bird isn't coming back anytime soon. Nor is the woolly mammoth. But a company working on technologies to bring back extinct species has attracted more investors, while other scientists are skeptical such feats are possible or a good idea.

Colossal Biosciences first announced its ambitious plan to revive the woolly mammoth two years ago, and on Tuesday said it wanted to bring back the dodo bird, too.

"The dodo is a symbol of man-made extinction," said Ben Lamm, a serial entrepreneur and co-founder and CEO of Colossal. The company has formed a division to focus on bird-related genetic technologies.

The last dodo, a flightless bird about the size of a turkey, was killed in 1681 on the island of Mauritius in the Indian Ocean.

The Dallas company, which launched in 2021, also announced Tuesday it had raised an additional $150 million in funding. To date, it has raised $225 million from wide-ranging investors that include United States Innovative Technology Fund, Breyer Capital and In-Q-Tel, the CIA's venture capital firm that invests in technology.

The prospect of bringing back the dodo isn't expected to directly make money, Lamm said. But the genetic tools and equipment that the company develops to try to do it may have other uses, including for human health care, he said.

For example, Colossal is now testing tools to tweak several parts of the genome simultaneously. It's also working on technologies for what is sometimes called an "artificial womb," he said.

The dodo's closest living relative is the Nicobar pigeon, said Beth Shapiro, a molecular biologist on Colossal's scientific advisory board, who has been studying the dodo for two decades. Shapiro is paid by the Howard Hughes Medical Institute, which also supports The Associated Press' Health and Science Department.

Her team plans to study DNA differences between the Nicobar pigeon and the dodo to understand "what are the genes that really make a dodo a dodo," she said.

The team may then attempt to edit Nicobar pigeon cells to make them resemble dodo cells. It may be possible to put the tweaked cells into developing eggs of other birds, such as pigeons or chickens, to create offspring that may in turn naturally produce dodo eggs, Shapiro said. The concept is still in an early theoretical stage for dodos.

Because animals are a product of both their genetics and their environment — which has changed dramatically since the 1600s — Shapiro said that "it's not possible to recreate a 100% identical copy of something that's gone."

Other scientists wonder if it's even advisable to try, and question whether "de-extinction" diverts attention and money away from efforts to save species still on Earth.

"There's a real hazard in saying that if we destroy nature, we can just put it back together again — because we can't," said Duke University ecologist Stuart Pimm, who has no connection to Colossal.

"And where on Earth would you put a woolly mammoth, other than in a cage?" asked Pimm, who noted that the ecosystems where mammoths lived disappeared long ago.

XS
SM
MD
LG